EUVIMEDEUVIMED entdecken
Open Access

Screening for small molecule inhibitors of SAH nucleosidase using an SAH riboswitch

Harini Sadeeshkumar, Aparaajita Balaji, Alan G Sutherland, Saraspadee Mootien, Karen G Anthony, Ronald R Breaker

Analytical Biochemistry · 2023

DOI: 10.1016/j.ab.2023.115047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Biochemistry, 2023. Verfasst von Harini Sadeeshkumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, 06520-8103, USA. Hauptthemen laut MEDLINE: Riboswitch. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Howard Hughes Medical Institute, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to the emergence of multidrug resistant pathogens, it is imperative to identify new targets for antibiotic drug discovery. The S-adenosylhomocysteine (SAH) nucleosidase enzyme is a promising target for antimicrobial drug development due to its critical functions in multiple bacterial processes including recycling of toxic byproducts of S-adenosylmethionine (SAM)-mediated reactions and producing the precursor of the universal quorum sensing signal, autoinducer-2 (AI-2). Riboswitches are structured RNA elements typically used by bacteria to precisely monitor and respond to changes in essential bacterial processes, including metabolism. Natural riboswitches fused to a reporter gene can be exploited to detect changes in metabolism or in physiological signaling. We performed a high-throughput screen (HTS) using an SAH-riboswitch controlled β-galactosidase reporter gene in Escherichia coli to discover small molecules that inhibit SAH recycling. We demonstrate that the assay strategy using SAH riboswitches to detect the effects of SAH nucleosidase inhibitors can quickly identify compounds that penetrate the barriers of Gram-negative bacterial cells and perturb pathways involving SAH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RiboswitchS-AdenosylmethionineRNABacteriaN-Glycosyl Hydrolases

Stichwörter der Autor:innen

AntibioticsHigh-throughput screeningNoncoding RNAS-adenosylhomocysteineS-adenosylmethionine

Substanzen

RiboswitchS-AdenosylmethionineRNAN-Glycosyl Hydrolases

Autor:innen und Institutionen

  • Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, 06520-8103, USA.
  • L2 Diagnostics, LLC, 300 George Street, New Haven, CT, 06511, USA.
  • Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, 06520-8103, USA; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, 06520-8103, USA; Howard…

Förderung

  • NIGMS NIH HHS
  • Howard Hughes Medical Institute
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Sadeeshkumar, H., Balaji, A., Sutherland, A. G., Mootien, S., Anthony, K. G., & Breaker, R. R. (2023). Screening for small molecule inhibitors of SAH nucleosidase using an SAH riboswitch. Analytical Biochemistry. https://doi.org/10.1016/j.ab.2023.115047

Vancouver

Sadeeshkumar H, Balaji A, Sutherland AG, Mootien S, Anthony KG, Breaker RR. Screening for small molecule inhibitors of SAH nucleosidase using an SAH riboswitch. Analytical Biochemistry. 2023. doi:10.1016/j.ab.2023.115047

BibTeX
@article{Sadeeshkumar2023,
  author = {Sadeeshkumar, Harini and Balaji, Aparaajita and Sutherland, Alan G and Mootien, Saraspadee and Anthony, Karen G and Breaker, Ronald R},
  title = {Screening for small molecule inhibitors of SAH nucleosidase using an SAH riboswitch},
  journal = {Analytical Biochemistry},
  year = {2023},
  doi = {10.1016/j.ab.2023.115047}
}
Kostenlos starten →